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In patients treated with CRT no data relative to the relationship between regional wall motion and perfusion and reverse
remodelling of the left ventricle at short and medium term followup were available. To this aim, 36 heart failure patients were
studied by G-SPECT before (T0), within 2 months (T1) and 6 months (T2) after CRT. A clinical followup was completed for
36 months. In 30/36 patients there was an improvement of NYHA Class at T1 that persisted at T2. G-SPECT showed signiﬁcant
improvement of perfusion at T1 in 92% of patients without further changes at T2. A reduction of LV volumes, an increase of EF
and an improvement of regional wall motion and thickening were observed at T1 versus baseline, with only minor changes at
T2. Moreover, baseline extension of perfusion defects was scarcely correlated with improvement after CRT. Finally, end diastolic
volume, perfusion defect and diabetes mellitus were independent predictors of survival. The main eﬀects of CRT on regional
myocardial perfusion and wall motion are obtained within 2 months. Volume overload modulates recovery of ventricular function
independently of reperfusion and, with extension of perfusion abnormalities and diabetes were independent predictors of survival
during followup.
1.Introduction
Progression of left ventricular dysfunction to heart failure
with low-ejection fraction (EF) is frequently accompanied
by impaired electromechanical coupling, which may further
diminish eﬀective ventricular systolic function. Cardiac
resynchronisation therapy (CRT) has been proposed as
treatment of patients with idiopathic as well as ischemic left
ventricular dysfunction with drug-refractory heart failure
and intra- and interventricular conduction delay [1, 2].
The physiological and mechanical eﬀects of CRT are well
d e s c r i b e di nl i t e r a t u r ei n[ 3, 4]a sw e l la st h ec h a n g e so f
regional myocardial perfusion and metabolism that con-
tribute to the beneﬁts observed in [5, 6]. However, despite
a signiﬁcant number of published studies [2–9], few data are
available regarding time of recovery of ventricular function.
In fact, studied populations were not comparable in terms
of followup time as well as in terms of imaging variables
analysed for outcome.
For this purpose, we studied a group of 36 patients sub-
mitted to CRT in order to identify the time course of
perfusion and wall motion changes at short- and medium-
termfollowup.Restmyocardialgatedsinglephotonemission
computedtomography(G-SPECT)wasusedtodetectsimul-
taneously perfusion, regional wall motion, EF and volumes.
All patients were followed up for 36 months.
2. Study Design
Thirty-six consecutive patients, 14 with ischemic (CAD)
and 22 patients with idiopathic (DCM) cardiomyopathy,
scheduled for CRT due to congestive heart failure, class
NYHA III and IV, left bundle branch block with QRS ≥
to 120ms, left ventricular ejection fraction (EF) ≤35%, and2 Cardiology Research and Practice
persisting symptoms despite maximal medical therapy, were
prospectively evaluated. Exclusion criteria were permanent
atrialﬁbrillation,signiﬁcantvalvularheartdisease,restrictive
or hypertrophic cardiomyopathy, suspected acute myocardi-
tis, acute coronary syndrome (<3 months), and severe
chronic obstructive pulmonary disease. Table 1 summarizes
clinical and demographic characteristics of the patients
before entering the study. After enrolment, gated SPECT
were obtained at rest before implantation (T0), repeated
within 60 days (T1) and after 6 months (T2). At enrolment
all patients were on optimal medical regimen that was
unchanged at the time of followup studies; those patients
requiring signiﬁcant changes in diuretics, ACE inhibitors,
digitalis and beta-blockers after CRT were excluded from the
study.In16/36patients,theCRTtreatmentwasanupgrading
of previous pacemaker (timing of previous implantation: 22
± 7 months). At baseline, 20/36 patients had a normal sinus
rhythm while those 16 who were upgraded had a pacemaker-
induced rhythm (7 with purely ventricular rhythm and 9
with residual atrial activity). The study was approved by
the local ethical committee. All patients signed an informed
consent to participate to the study.
2.1. Device Implantation. A permanent biventricular trans-
venous pacing system was implanted in the patients
(Guidant—Renewal 2 in 19 patients and Medtronic-Insync
III in the remaining 17). Devices were programmed to max-
imise biventricular pacing throughout the range of expected
patients activity and to minimise power output to prolong
battery life. Further optimisation of atrio-ventricular delay
wasperformedusingDopplertransmitralﬂowtoprovidethe
maximumleftventricularﬁllingtimewithoutcompromising
cardiac resynchronisation. The AV delay was set at a value
that provided maximum separation of the E and A waves, in
order to select the shortest AV delay without compromising
the left atrial contribution to the left ventricular ﬁlling.
2.2. Gated SPECT. Gated SPECT acquisition began 45 to
60min after 99m Tc Tetrofosmin injection at rest (up to
450MBq). A double-head gamma camera equipped with
high-resolution collimators was used. A 64 × 64 matrix,
32 projections, 40 seconds projections, 16 frames/cycle
protocol were applied in association with appropriate energy
photopeaks. All studies were reconstructed using ﬁltered
backprojection without attenuation or scatter correction. An
operator independent analysis of regional wall motion and
wall thickening was performed using previously validated
software for quantitative gated SPECT analysis (QGS, Cedars
Sinai, US), providing scores of regional wall motion (from 0
= normal to 5 = dyskinesis) and wall thickening (from 0 =
normal to 3 = absent) in a 20-segment polar map. Summed
motion scores (SMSs) and summed thickening scores (STSs)
were automatically calculated by adding regional scores. Left
ventricular end diastolic volume (EDVi) and end systolic
volume (ESVi) were calculated using the same programme
and normalized to the body surface area. Regional perfusion
was assessed qualitatively by the consensus of two skilled
observers, comparing baseline and followup images and
Table 1: Clinical and Demographic Characteristics of patients.
EF: ejection fraction, MI: myocardial infarction, NYHA: New York
Heart Association, EDVi: end diastolic volume index, ESVi: end
systolic volume index, and Q: ﬂow rate.
n = 36
Mean age (years) 70 ± 8
S e x( m a l e ) 2 4( 6 7 % )
EF 22.2 ± 3%
Diabetes 21 (58%)
Hypertension 25 (79%)
MI site Anterior: 8 (60%)
Inferior: 6 (40%)
NYHA class 3.1 ± 0.4
EDVi 141.2 ± 60.5ml/m2
ESVi 129.2 ± 50.6ml/m2
Motion extension 63 ± 19%
Summed Motion Score 48.9 ± 11.5
Summed Rest Score 14.5 ± 12.6
Summed Thickening score 34.4 ± 6.1
Q Aortic 158 ± 46
Q Pulmonary 114 ± 36
identifying those segments with improvement or reduction
of perfusion using a 5-point score (from 0 = normal to 4
absent perfusion) in the same 20-segment polar map [10].
Moreover, regional perfusion was assessed also by means
of a quantitative perfusion score (QPS, Cedars Sinai, US),
providing % regional uptake in the same 20-segment polar
map. By adding the 20-segment scores, a summed rest
scores (SRSs) were automatically calculated. A SRS < 4w a s
considered as normal, 4 to 8 as mild to moderate and >8a s
extensive perfusion defects [11].
2.3. Followup. According to the followup program of our
Institute, one year after CRT, each patient was evaluated by
medical interview, physical examination and 12-lead ECG.
Furthermore, patients were followedup for additional 12 to
36 months by telephone calls or mail questionnaires. We
deﬁned as cardiac events: cardiac death, nonfatal myocar-
dial infarction, coronary revascularization by percutaneous
coronaryinterventionsorbypasssurgery,andhospitalisation
for cardiac ischemic events. No one of the enrolled patients
was lost to followup. In particular, 4 patients who could be
initially considered for the enrollment were excluded from
the studied population because two patients died up to 60
days of followup and two up to 6 months. All patients were
informed of the observational and investigative nature of the
study and gave their written informed consent.
3.StatisticalAnalysis
Resultsareexpressedasmean±SD.Variableswerecompared
with the Students t-test for paired or unpaired samples, and
with the ANOVA test. A P value < .05 was considered statis-
tically signiﬁcant. Linear regression analysis was performedCardiology Research and Practice 3
Table 2: Value of scintigraphic variable obtained at baseline and at
short- and medium-term of followup. T0: time 0, T1: ﬁrst step of
followup, T2: second step of followup. EDVi: end diastolic volume
index, ESVi: end systolic volume index, SMS: summed motion
score, STS: summed thickening score, SRS: summed rest score, and
EF: ejection fraction.
Variables
(mean)
T0 T1 T2 Diﬀerence T1-T2
EDVi 167.75 144.66∗∗∗ 138.79∗∗∗ −5.87n.s.
ESVi 133.97 112.55∗∗∗ 105.41∗∗∗ −7.14n.s.
SMS 48.91 40.42∗∗∗ 38.47∗∗∗ −1.95n.s.
STS 34.41 31.25∗∗ 31.11∗∗ −0.14 n.s.
SRS 14.69 11.58∗∗ 12.06∗∗ +0.48n.s.
EF 22.27 27.38∗∗∗ 28.64∗∗∗ +1.26 n.s.
∗∗P < .05 versus T0; ∗∗∗P < .01 versus T0; n.s.: not signiﬁcant.
to evaluate relations between variables. Chi-square test was
used to test the independence between categorical variables.
All quantitative G-SPECT variables (EF, EDVi, ESVi,
SMS, STS, and SRS) were examined to test the diﬀerences
and correlations between T0, T1, and T2.
The independent predictors of survival free from cardiac
death were identiﬁed using multivariate Cox regression
analysis,andincludingallthevariablescollected.Abackward
elimination procedure was used to select the independent
variables: that is, those resulted to be signiﬁcant.
4. Results
4.1. Clinical and Electrocardiographic Findings. Implantation
was successful in all patients and no complications were
reported. Left ventricular pacing leads were positioned in
lateral (18 patients), anterior (6 patients), or posterior (12
patients)cardiacveins.AllbutthreepatientsshowedaNHYA
class improvement at T1 that was conﬁrmed at T2.
4.2. Diﬀerences between CAD and DCM Patients. When clin-
ical and quantitative variables were examined in CAD
and DCM patients, respectively, no diﬀerences was found
between baseline NYHA Class (P = .215), EDVi (P = .977),
ESVi (P = .910), EF (P = .210), SMS (P = .734), and STS (P
= .812). As expected, the only statistically diﬀerent variable
was SRS (25.5 versus 7.8, P = .0001, resp. in CAD and DCM
patients).
4.3. Time to Recovery and Correlation between Variables.
The analysis of all G-SPECT variables showed signiﬁcant
diﬀerences between T0 and T1 as well as T2 (Table 2).
However, the major eﬀects were found in the ﬁrst 2 months,
whileat6monthstherewereonlyminorchanges(Tables3(a)
and 3(b)).
The volume reduction observed at T1 was inversely
correlated to the volume overload at T0 (P = .0025). Those
patients with the highest volume overload showed less
ventricular reverse remodelling and improvement of clinical
variables. In particular, 11 patients (average EDVi: 201 ±
25ml/m2 andESV i172±18ml/m2 atT0)showednoreverse
remodelling or improvement in clinical variables (average
EDVi: 205 ± 19ml/m2 and ESVi 176 ± 13ml/m2 at T1,
P = ns versus T0). On the contrary, at T2 perfusion and
wallmotiondatareﬂectedtheresultsobtainedintheﬁrsttwo
months, without signiﬁcant changes (P = .455 and P = .348,
resp., for perfusion and wall motion abnormalities at T2
versus T1). The same results were obtained when CAD and
DCM patients were analysed separately.
4.4. Perfusion Analysis. T1 qualitative perfusion analysis
indicated that in all but 3 patients there was a signiﬁcant
improvement of tracer uptake at rest (mean value of
qualitative score in the polar map 14 versus 10.5 and 11
at T0 versus T1 and T2, P = .0035, resp.). The segments
t h a tb e n e ﬁ tm o s tf r o mC R Ti nt e r m so fp e r f u s i o nw e r e
anterior septum (24 patients), inferior septum (22 patients),
inferior wall (generally in the distal portion, 16 patients),
anterior wall (7 patients), while in only 2 patients there
was an improvement in posterior and lateral wall. All but 3
patients showed relationship between site of improvement
of tracer uptake and pacing lead position. However in all
these patients improvement of perfusion was detected also
in a control area. No signiﬁcant diﬀerences were observed
between T1 and T2 at qualitative analysis. The same results
were obtained with quantitative analysis (Table 2).
The qualitative as well as quantitative analysis of SRS
indicated that perfusion parameters were not correlated with
other variables in predicting patient’s outcome. As a matter
of fact, perfusion score, obtained from all 36 patients, at
T0 was scarcely correlated with the volume reduction and
improvement of function at T1 and at T2.
No signiﬁcant diﬀerences were observed when the same
variables were analysed separately in CAD and DCM
patients.
4.5. Followup. Three patients (2 male and 1 female) died for
end-stage heart failure during followup (two of them up to
12 months and one after 24 months).
Using Cox proportional hazard regression analysis, a
EDVi (Hazard ratio 1.02; 95% conﬁdence Intervals 1.00–
1.24; χ2 = 31.12; P = .00002), SRS (Hazard ratio 1.15; 95%
conﬁdence Intervals 1.05–1.29; χ2 = 27.30; P = .00003),
and diabetes mellitus (Hazard ratio 2.51; 95% conﬁdence
Intervals 1.18–4.75; χ2 = 18.76; P = .0013) were independent
predictors of survival during followup. No correlation was
found between the presence of coronary artery disease and
cardiac events during followup (P = .19).
5. Discussion
Previous studies demonstrated that CRT may improve
cardiacfunctionandclinicalstatusinpatientswithmoderate
to severe heart failure and a prolonged QRS interval [3–
5]. However, despite the presence of several published
studies, few data are available regarding the time sequence
of improvement after resynchronization and the behaviour4 Cardiology Research and Practice
of functional and perfusion variables in these patients before
and after CRT.
Our results indicate that the main eﬀects of CRT on
global function and regional myocardial perfusion are
obtained within 2 months and are stable over a period of
6 months. Moreover, volume overload modulates recovery
of regional and global ventricular function independently
of reperfusion both at short- and medium-term followup.
Finally, reperfusion is a common ﬁnding after CRT and it
is not coupled to recovery of function at short- as well as
medium-termfollowup.Onthisbasis,gatedSPECTprovides
diagnostic and pathophysiological information that should
be carefully evaluated in heart failure patients suitable for
CRT.
5.1. Time to Recovery. One of the main results obtained
by this study is relative to time to recovery after CRT. In
our knowledge, this is the ﬁrst study showing that CRT
beneﬁts are evident within 60 days after resynchronisation
and thereafter remain stable or follow the trend of the
ﬁrst two months over a range of 6 months. This result
could be helpful in the strategy of the followup exami-
nations of resynchronized patients. A possible explanation
of this phenomenon could be due to an acute mechanical
eﬀect of CRT [3, 4] with a subsequent improving of the
hemodynamic, that is particularly evident in patients with
poor or moderate volume overload. On the contrary, beneﬁt
of CRT is limited by the degree of volume overload like
in other categories of patients such as those with viable
myocardium undergoing coronary revascularization or with
valvular diseases undergoing surgery [12, 13]. In patients
without improvement after CRT, recovery of function and
perfusion is not observed at the ﬁrst followup control as well
as after 6 months.
5.2. CRT Eﬃcacy. The multiple eﬀects of CRT include com-
plex perfusion and metabolic changes that may explain some
of the short- and medium-term beneﬁts independently of
wall motion or hemodynamic changes. Our study conﬁrms
previous clinical observations showing an improvement in
heart failure symptoms, also in patients without signiﬁcant
volume reduction, and introduces the concept of reperfusion
not limited to the septal but extended to the anterior,
inferior and lateral wall. As a matter of fact, reperfusion is
independent not only by symptoms but also by recovery of
function, indicating that CRT works on a wide spectrum
that includes perfusion as well as function. Probably, the
“mismatch” of reperfusion without any apparent improve-
ment in wall motion could identify those patients in whom
the clinical improvement is not obtained merely by a
volumetric resynchronisation but mostly by a normalization
of myocardial blood ﬂow.
5.3. Followup. Despite the small number of patients, our
data demonstrated that volume overload and extension of
perfusion defects were the most important variables in
determining event-free survival in patients with as well as
in patients without coronary artery disease. The absence
Table 3: Correlation matrix between percent of variation of the
analysed variables. T0: time 0, T1: ﬁrst step of followup, T2: second
step of followup. EDVi: end diastolic volume index, ESVi: end
systolic volume index, SMS: summed motion score, STS: summed
thickening score, SRS: summed rest score, and EF: ejection fraction.
(a) Percent of variable variations at T1.
%o fv a r i a t i o n sT 0v e r s u sT 1
Corr. EDVi ESVi SMS STS SRS FE
EDVi 1
ESVi 0.945∗∗∗ 1
SMS 0.407∗∗ 0.578∗∗∗ 1
STS 0.556∗∗∗ 0.716∗∗∗ 0.864∗∗∗ 1
SRS 0.417∗∗ 0.391∗∗ —— 1
FE −0.699∗∗∗ −0.819∗∗∗ −0.740∗∗∗ −0.799∗∗∗ —1
(b) Percent of variable variations between T1 and T2.
%o fv a r i a t i o n sT 1v e r s u sT 2
Corr. EDVi ESVi SMS STS SRS FE
EDVi 1
ESVi 0.801∗∗∗ 1
SMS 0.330∗ 0.567∗∗∗ 1
STS 0.429∗∗∗ 0.485∗∗∗ 0.631∗∗∗ 1
SRS — — 0.377∗∗ 0.500∗∗∗ 1
FE −0.473∗∗∗ −0.676∗∗∗ −0.792∗∗∗ −0.403∗∗ —1
∗∗∗P < ,01 ∗∗P < ,05 ∗P < ,1.
of a signiﬁcant diﬀerence in cardiac mortality between
the two groups at 3 years, was a very interesting result.
Thus, in clinical practice, the need for additional imaging
variables, such as extension of scar and volumes, seems
to be necessary before CRT, according to standard risk
stratiﬁcation.
5.4. Limitations. The study population includes 36 patients
a n dt h u ss o m eo fo u rc o n c l u s i o n sm a ys u ﬀer from this lim-
ited group. The diﬃculty of maintaining the same medical
treatment from baseline to followup and the occurrence of
death in two patients with severe volume overload reduced
thestudygroupbutatthesametimeavoidedanyinterference
from medical therapy, a variable frequently underestimated
in followup studies. Perfusion was evaluated only at rest,
and thus all considerations concerning Tetrofosmin uptake
linearity with coronary blood ﬂow should not limit our
results. The limits of QGS underestimation of absolute
volumes in severe dysfunctioning patients should not aﬀect
our conclusions since all patients were processed in the
same way before and after CRT. The limit of correctly
identifying myocardial borders in such dilated hearts was
always checked and corrected with operator manual experi-
ence.
Finally, a control group of dysfunctioning patients who
did not undergo CRT but who were submitted to gated
SPECT has not been included in the study because of ethical
implication in order to reduce radiation exposure.Cardiology Research and Practice 5
6. Conclusions
This study demonstrated that the main eﬀects of CRT
on regional myocardial perfusion and wall motion are
obtained within 2 months and are stable over a period
of 6 months. Volume overload modulates recovery of
regional and global ventricular function independently of
reperfusion both at short- and medium-term followup.
Moreover, extension of perfusion defects as well as volume
overload were the most important variable in determining
event free survival in the followup. Finally, this study also
demonstrates that CRT works on a wide spectrum that
ranges from QRS to perfusion, and that some unexplained
beneﬁcial eﬀects may be due to reperfusion beyond mechan-
ical eﬀects.
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